These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 36891783)
1. Mechanisms of diabetic foot ulceration: A review. Deng H; Li B; Shen Q; Zhang C; Kuang L; Chen R; Wang S; Ma Z; Li G J Diabetes; 2023 Apr; 15(4):299-312. PubMed ID: 36891783 [TBL] [Abstract][Full Text] [Related]
3. The role of CXCL8 in chronic nonhealing diabetic foot ulcers and phenotypic changes in fibroblasts: a molecular perspective. Rai V; Moellmer R; Agrawal DK Mol Biol Rep; 2022 Feb; 49(2):1565-1572. PubMed ID: 35044539 [TBL] [Abstract][Full Text] [Related]
4. Single-cell profiling reveals transcriptomic signatures of vascular endothelial cells in non-healing diabetic foot ulcers. Lu Y; Liu X; Zhao J; Bie F; Liu Y; Xie J; Wang P; Zhu J; Xiong Y; Qin S; Yang F; Chen L; Xu Y Front Endocrinol (Lausanne); 2023; 14():1275612. PubMed ID: 38107519 [TBL] [Abstract][Full Text] [Related]
5. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers. Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012 [TBL] [Abstract][Full Text] [Related]
6. Impaired dermal microvascular reactivity and implications for diabetic wound formation and healing: an evidence review. O'Brien TD J Wound Care; 2020 Sep; 29(Sup9):S21-S28. PubMed ID: 32924808 [TBL] [Abstract][Full Text] [Related]
7. S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus. Trøstrup H; Holstein P; Christophersen L; Jørgensen B; Karlsmark T; Høiby N; Moser C; Ågren MS Arch Dermatol Res; 2016 Jul; 308(5):347-55. PubMed ID: 27084691 [TBL] [Abstract][Full Text] [Related]
8. Role of fibroblast plasticity and heterogeneity in modulating angiogenesis and healing in the diabetic foot ulcer. Rai V; Moellmer R; Agrawal DK Mol Biol Rep; 2023 Feb; 50(2):1913-1929. PubMed ID: 36528662 [TBL] [Abstract][Full Text] [Related]
9. Translational development of ABCB5 Kerstan A; Dieter K; Niebergall-Roth E; Klingele S; Jünger M; Hasslacher C; Daeschlein G; Stemler L; Meyer-Pannwitt U; Schubert K; Klausmann G; Raab T; Goebeler M; Kraft K; Esterlechner J; Schröder HM; Sadeghi S; Ballikaya S; Gasser M; Waaga-Gasser AM; Murphy GF; Orgill DP; Frank NY; Ganss C; Scharffetter-Kochanek K; Frank MH; Kluth MA Stem Cell Res Ther; 2022 Sep; 13(1):455. PubMed ID: 36064604 [TBL] [Abstract][Full Text] [Related]
10. Neuropeptides, Inflammation, Biofilms, and diabetic Foot Ulcers. Yang S; Hu L; Han R; Yang Y Exp Clin Endocrinol Diabetes; 2022 Jul; 130(7):439-446. PubMed ID: 34225369 [TBL] [Abstract][Full Text] [Related]
11. Targeting DNA methylation and demethylation in diabetic foot ulcers. Deng JY; Wu XQ; He WJ; Liao X; Tang M; Nie XQ J Adv Res; 2023 Dec; 54():119-131. PubMed ID: 36706989 [TBL] [Abstract][Full Text] [Related]
12. The role of stem cells in the treatment of diabetic foot ulcers. Blumberg SN; Berger A; Hwang L; Pastar I; Warren SM; Chen W Diabetes Res Clin Pract; 2012 Apr; 96(1):1-9. PubMed ID: 22142631 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the microenvironment of diabetic foot ulcers and potential drug identification based on scRNA-seq. Li Y; Ju S; Li X; Li W; Zhou S; Wang G; Cai Y; Dong Z Front Endocrinol (Lausanne); 2022; 13():997880. PubMed ID: 36686438 [TBL] [Abstract][Full Text] [Related]
14. Genome-wide DNA methylation analysis identifies a metabolic memory profile in patient-derived diabetic foot ulcer fibroblasts. Park LK; Maione AG; Smith A; Gerami-Naini B; Iyer LK; Mooney DJ; Veves A; Garlick JA Epigenetics; 2014 Oct; 9(10):1339-49. PubMed ID: 25437049 [TBL] [Abstract][Full Text] [Related]
15. Nonpharmacological Management of Diabetic Foot Ulcers: An Update. Eleftheriadou I; Samakidou G; Tentolouris A; Papanas N; Tentolouris N Int J Low Extrem Wounds; 2021 Sep; 20(3):188-197. PubMed ID: 33073653 [TBL] [Abstract][Full Text] [Related]
16. Toward Developing Immunocompetent Diabetic Foot Ulcer-on-a-Chip Models for Drug Testing. Ejiugwo M; Rochev Y; Gethin G; O'Connor G Tissue Eng Part C Methods; 2021 Feb; 27(2):77-88. PubMed ID: 33406980 [TBL] [Abstract][Full Text] [Related]
17. Distal symmetrical polyneuropathy is present in all individuals with diabetes and foot ulcers - and does not associate with healing time. Mizrak HI; Hansen TW; Andersen JA; Rossing P; Rasmussen A; Hansen CS J Diabetes Complications; 2022 Dec; 36(12):108353. PubMed ID: 36370668 [TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Polymer-based Wound Dressings for the Treatment of Diabetic Foot Ulcer: An Overview of State-of-the-art. Hussain Z; Thu HE; Shuid AN; Katas H; Hussain F Curr Drug Targets; 2018; 19(5):527-550. PubMed ID: 28676002 [TBL] [Abstract][Full Text] [Related]
19. A Meta-Analysis of the Outcomes of Metatarsal Head Resection for the Treatment of Neuropathic Diabetic Foot Ulcers. Yammine K; Kheir N; Assi C Adv Wound Care (New Rochelle); 2021 Feb; 10(2):81-90. PubMed ID: 32870773 [No Abstract] [Full Text] [Related]
20. Outcomes Following Advanced Wound Care for Diabetic Foot Ulcers: A Canadian Study. Roth-Albin I; Mai SHC; Ahmed Z; Cheng J; Choong K; Mayer PV Can J Diabetes; 2017 Feb; 41(1):26-32. PubMed ID: 27634016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]